`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC., and AKORN INC.,1
`Petitioners,
`
`v.
`
`SAINT REGIS MOHAWK TRIBE,
`Patent Owner.
`_______________________
`Case IPR2016-01127 (8,685,930 B2)
`Case IPR2016-01128 (8,629,111 B2)
`Case IPR2016-01129 (8,642,556 B2)
`Case IPR2016-01130 (8,633,162 B2)
`Case IPR2016-01131 (8,648,048 B2)
`Case IPR2016-01132 (9,248,191 B2)
`__________________________
`PATENT OWNER’S UPDATED MANDATAORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`
`
` 1
`
` Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017-00596,
`IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017-00599,
`IPR2017-00585 and IPR2017-00600, and IPR2017-00601 have respectively been
`joined with the captioned proceedings. The word-for-word identical page is filed
`in each proceeding identified in the caption pursuant to the Board’s Scheduling
`Order (Paper 10).
`
`
`
`Under 37 C.F.R. § 42.8(a)(3), Patent Owner Saint Regis Mohawk Tribe
`
`hereby submits the following mandatory change-of-information notice in the
`
`consolidated cases listed in the caption above.
`
`
`
`A. Real Party-In-Interest – 37 CFR § 42.8(b)(1) - Unchanged.
`
`B. Related Matters – 37 C.F.R. § 42.8(b)(2)
`
`On Monday, October 16, 2017, Judge Bryson ruled on Allergan’s motion to
`
`join the Tribe as a co-plaintiff in the case styled Allergan, Inc. & Saint Regis
`
`Mohawk Tribe v. Teva Pharmaceuticals USA, Inc., et al, 15-cv-1455, Dkt. 522
`
`(E.D. Tex.). Judge Bryson noted that “[i]f the assignment to the Tribe is valid, the
`
`Tribe should be added as a co-plaintiff. If the Assignment to the tribe is invalid, it
`
`would not be necessary to add the Tribe as a co-plaintiff.” Id. at 8. Judge Bryson
`
`then added the Tribe as a co-plaintiff. Id. at 10.
`
`That same day, Judge Bryson also issued a Final Judgment (Dkt. 524)
`
`finding the asserted claims invalid under 35 U.S.C. § 103:
`
`
`
`
`
`1
`
`
`
`C. Lead and Back-up Counsel – 37 C.F.R. § 42.8(b)(3)
`
`The Tribe is exclusively represented in this proceeding by the following
`
`Back-Up Counsel:
`
`BACK-UP COUNSEL
`Alfonso Chan, Reg. No. 45,964
`SHORE CHAN DEPUMPO LLP
`901 Main Street, Suite 3300
`Dallas, TX 75202
`Telephone: (214) 593-9110
`Email: achan@shorechan.com
`Fax: (214) 593-9111
`Michael W. Shore
`SHORE CHAN DEPUMPO LLP
`901 Main Street, Suite 3300
`Dallas, TX 75202
`Telephone: (214) 593-9110
`Email: mshore@shorechan.com
`Fax: (214) 593-9111
`Marsha K. Schmidt
`Attorney at Law
`14928 Perrywood Drive
`Burtonsville, MD 20866
`Email: marsha@mkschmidtlaw.com
`Tel: (301) 949-5176
`
`
`Joseph DePumpo, Reg. No. 38,124
`SHORE CHAN DEPUMPO LLP
`901 Main Street, Suite 3300
`Dallas, TX 75202
`Telephone: (214) 593-9110
`Email: jdepumpo@shorechan.com
`Fax: (214) 593-9111
`Christopher L. Evans
`SHORE CHAN DEPUMPO LLP
`901 Main Street, Suite 3300
`Dallas, TX 75202
`Telephone: (214) 593-9110
`Email: cevans@shorechan.com
`Fax: (214) 593-9111
`
`
`D. Electronic Service
`The Tribe consents to service by email at IPR01227@shorechan.com and
`
`the email addresses listed for counsel above.
`
`Dated: October 18, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/ Alfonso G. Chan /
`Alfonso G. Chan
`Reg. No. 45,964
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on October 18, 2017, a complete and entire copy of Patent Owner’s Updated
`
`Mandatory Notices Pursuant to 37 C.F.R. § 42.8(a)(3) was provided, via electronic
`
`service, to the Petitioners by serving the correspondence address of record as
`
`follows:
`
`Steven W. Parmelee
`Michael T. Rosato
`Jad A. Mills
`WILSON SONSINI GOODRICH & ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`
`Wendy L. Devine
`WILSON SONSINI GOODRICH & ROSATI
`One Market Street, Spear Tower Floor 33
`San Francisco, CA 94105-1126
`wdevine@wsgr.com
`
`Douglas H. Carsten
`WILSON SONSINI GOODRICH & ROSATI
`12235 El Camino Real, Suite 200
`San Diego, CA 92130
`dcarsten@wsgr.com
`
`Richard Torczon
`WILSON SONSINI GOODRICH & ROSATI
`1700 K Street NW, 5th Floor
`Washington, DC 20006
`rtorczon@wsgr.com
`
`
`
`
`Brandon M. White
`Crystal Canterbury
`Charles G. Curtis, Jr.
`Jennifer MacLean
`Benjamin S. Sharp
`Shannon M. Bloodworth
`PERKINS COIE LLP
`700 13th Street NW
`Washington DC 20005
`bmwhite@perkinscoie.com
`ccanterbury@perkinscoie.com
`ccurtis@perkinscoie.com
`jmaclean@perkinscoie.com
`bsharp@perkinscoie.com
`sbloodworth@perkinscoie.com
`
`Eric D. Miller
`PERKINS COIE LLP
`1201 Third Avenue, Suite 4900
`Seattle, WA 98101-3099
`emiller@perkinscoie.com
`Counsel for Mylan Pharmaceuticas, Inc.
`
`Michael R. Dzwonczyk
`Azy S. Kokabi
`Travis B. Ribar
`SUGHRUE MION, PLLC
`2100 Pennsylvania Ave., NW, Suite 800
`Washington, DC 20037
`mdzwonczyk@sughrue.com
`akokabi@sughrue.com
`tribar@sughrue.com
`Attorneys for Akorn Inc.
`
`
`And upon the remaining Petitioners as follows:
`
`
`
`
`
`Gary J. Speier
`Mark D. Schuman
`CARLSON, CASPERS, VANDENBURGH, LINDQUIST & SCHUMAN, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`gspeier@carlsoncaspers.com
`mschuman@carlsoncaspers.com
`IPRCyclosporine@carlsoncaspers.com
`Attorneys for Teva Pharmaceuticals
`
`
`
`
`
`
`
`
`
`/Alfonso G. Chan/
`Alfonso G. Chan
`
`SHORE CHAN DEPUMPO LLP
`
`901 Main Street, Suite 3300
`Dallas, Texas 75202
`(214) 593-9110
`
`
`
`
`
`
`
`